Hao-Wei Teng

8PUBLICATIONS
15CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 04, 2024
Combining moderate dosage of Bevacizumab with TAS-102 provides longer progression-free time in refractory metastatic colorectal Cancer.

Kuan-Yu Tseng, Mu-Ying Yang, Wei-Shone Chen

|Oct 26, 2024
Expert consensus on the optimal management of BRAFV600E-mutant metastatic colorectal cancer in the Asia-Pacific region.

Oliver Piercey, Lorraine Chantrill, Hung-Chih Hsu

|Feb 12, 2024
Interferon Gamma Induces Higher Neutrophil Extracellular Traps Leading to Tumor-Killing Activity in Microsatellite Stable Colorectal Cancer.

Hao-Wei Teng, Tean-Ya Wang, Chun-Chi Lin

|Jul 02, 2021
Insulin-Like Growth Factor 2 mRNA-Binding Protein 1 (IGF2BP1) Is a Prognostic Biomarker and Associated with Chemotherapy Responsiveness in Colorectal Cancer.

Hung-Ming Chen, Chun-Chi Lin, Wei-Shone Chen

|Jun 30, 2021
The efficacy of anti-EGFR therapy in treating metastatic colorectal cancer differs between the middle/low rectum and the left-sided colon.

Kun-Han Lee, Wei-Shone Chen, Jeng-Kai Jiang

|Nov 17, 2020
Effect of Primary Tumor Location on Postmetastasectomy Survival in Patients with Colorectal Cancer Liver Metastasis.

Tien-Hua Chen, Wei-Shone Chen, Jeng-Kai Jiang

Pageof 2

Frequent Collaborators

2 joint publications

Chun-Chi Lin

1 joint publications

Kun-Han Lee

1 joint publications

Shih-Ching Chang

1 joint publications

Yee Chao